Entheogen Resurgence

Brief Summary

For the purpose of this anonymous, observational pilot survey, the investigators will define "entheogens" as substances, generally derived from plants, that are ingested in order to impact one's consciousness for therapeutic, religious, or spiritual purposes. This survey will focus on the naturalistic use of entheogens and other substances including kambo, ayahuasca, hapé, bufo, and sananga typically used in specific cultural and spiritual contexts for healing. There are substantial limitations to what the healthcare community knows about the intentions, motivations, experiences, health behaviors, and demographics of people who decide to participate in entheogen therapy centers or retreats and their willingness to participate in future research studies. The primary goal of this observational pilot survey is to collect self-reported, anonymous data from people who have opted to participate in entheogen therapy centers and retreats during the last five (5) years on the topics of their initial intentions, motivations, experiences, demographics, and willingness to participate in future entheogen research. With the support of established therapy and retreat centers, the research team will aim to collect 100 survey responses from unique, unidentified individuals who have participated in some form of entheogen therapy or treatment during the last five (5) years. Those who choose to fill out the survey will be at least 18 years of age, fluent in English, and self-reporting participation in therapy or a retreat which utilized entheogens in a naturalistic setting in the past five (5) years.

Intervention / Treatment

  • self-reported entheogen use (OTHER)
    self-reported participation in therapy or a retreat in a naturalistic setting that incorporated the use of entheogens in the past five (5) years

Condition or Disease

  • Psychedelic Experiences

Phase

Study Design

Study type: OBSERVATIONAL
Status: Completed
Study results: No Results Available
Age: 18 Years and older   (Adult, Older Adult)
Enrollment: 102 (ACTUAL)
Funded by: Other
Time Perspective: Cross-Sectional
Observational Model: Cohort

Masking

Clinical Trial Dates

Start date: Sep 16, 2021 ACTUAL
Primary Completion: Jan 12, 2022 ACTUAL
Completion Date: Jan 12, 2022 ACTUAL
Study First Posted: Sep 13, 2021 ACTUAL
Last Updated: Jan 26, 2022

Sponsors / Collaborators

Lead Sponsor: Vireo Health
Lead sponsor is responsible party
Responsible Party: N/A

Eligibility Criteria

Sex: All
Minimum Age: 18
Age Groups: Adult / Older Adult
Healthy Volunteers: Yes

Inclusion Criteria:

* \>18 years old
* Fluent in English
* Self-reported participation in therapy or a retreat in a naturalistic setting that incorporated the use of entheogens in the past five (5) years

Exclusion Criteria:

* Inability to provide informed consent
* Inability to complete the online questionnaire
* No self-reported participation in therapy or a retreat in a naturalistic setting that incorporated the use of entheogens in the past five (5) years
* Self-reported participation in therapy or a retreat in naturalistic setting that incorporated the use of entheogens greater than five (5) years ago

Primary Outcomes
  • The primary outcome will be self-reported experiences related to entheogen use in naturalistic retreat and therapeutic settings.

More Details

NCT Number: NCT05042765
Acronym: SERPNTS
Other IDs: #2021-61137
Study URL: https://clinicaltrials.gov/study/NCT05042765
Last updated: Sep 29, 2023